Fredun Pharmaceuticals (FREDUN) — concall transcript

📢 Key Event
Fredun Pharmaceuticals reported strong Q1 FY27 growth with 90.44% revenue and 94.63% net profit growth, targeting 30-35% growth over 3-5 years via capacity expansion and margin improvement.

🔄 What Changed
90.44% revenue growth, 94.63% net profit growth, 30-35% growth projection, INR30-40 crores CapEx this year, inventory reduction target to 110-125 days, pet care revenue target of INR100 crores in 3 years, 70-75% gross margin on Dermaceutics

🔮 What's Next
INR800 crores revenue target for current year, INR35-45 crores CapEx next year, pet care revenue to reach INR100 crores within 3 years, inventory reduction to 110-125 days within 4 quarters

💡 Investor Takeaway
Shareholders should note that growth is being driven by high-growth new brands and strategic capacity expansion, with margin improvement expected from higher-margin products and operational efficiencies, not just volume growth.

Fredun Pharmaceuticals reported 90.44% YoY revenue growth to INR 228.25 crores and 94.63% YoY net profit growth to INR 13.17 crores for Q1 FY27, driven by 35-45% growth in new age brands and 15-20% growth in vintage business. Management highlighted plans for capacity expansion across 5 plants and 43 new locations to target 30-35% growth over 3-5 years, with INR30-40 crores CapEx this year and INR35-45 crores next year. Inventory is being reduced from 135-140 to 110-125 days, and pet care revenue is targeted at INR100 crores within 3 years from current INR40-43 crores. Gross margins are expected to improve through higher-margin products like Dermaceutics (70-75% gross margin) and functional foods, supported by organizational efficiency and a stable leadership team with 10-25 year experienced divisional CEOs.

📄 View Original Announcement (PDF)

📊 Stock Analysis — FREDUN ✨ Ask AI About This

About Fredun Pharmaceuticals Ltd (FREDUN)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹2,020.29 Cr P/E: 14.3 ROE: 16.6% ROCE: 20.5% Div Yield: 0.06%

View full FREDUN stock details →

📡 Get AI alerts when FREDUN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FREDUN — Free

💡 Ask AI about this filing

"What is the timeline for achieving INR800 crores revenue target?" "When will inventory days be reduced to 110-125 days?" "What specific diagnostics or grooming acquisitions are planned for pet care?"

Ask AI Free →

📊 More FREDUN filings

See all FREDUN filings →

🔥 Also filed on 30 June 2026

SHIRPUR-G Shirpur Gold Refinery Limited Announcement REFEX Refex Industries Limited Corporate Action ROLLT Rollatainers Limited Announcement SAMMAANCAP Sammaan Capital Limited Corporate Action RUSTOMJEE Keystone Realtors Limited Announcement ZEEMEDIA Zee Media Corporation Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FREDUN files new disclosures

Track FREDUN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FREDUN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd